share

γ-(3-(3-Amino-2,4,6-Trijod-Benzoylamino)-Phenyl)-Buttersaure [Germ An] CAS NO 22708-53-8


Unit Price:

CAS No.:22708-53-8

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

γ-(3-(3-Amino-2,4,6-Trijod-Benzoylamino)-Phenyl)-Buttersaure [Germ An] is a specialized iodinated organic compound, a key intermediate in the synthesis of advanced contrast media for diagnostic imaging. Its value lies in its precise molecular structure, which is engineered to provide high X-ray attenuation and targeted biodistribution, making it critical for producing safe and effective radiopharmaceuticals. This product is essential for manufacturers in the pharmaceutical and biotechnology sectors focused on developing next-generation non-ionic, low-osmolar contrast agents for computed tomography (CT) and angiography.

Application

  • Pharmaceutical Intermediate: Primary building block for synthesizing non-ionic iodinated contrast media.
  • Contrast Agent Development: Used in R&D for creating novel X-ray and CT scan contrast agents with improved safety profiles.
  • Bioconjugation Precursor: Serves as a starting material for attaching iodine-rich moieties to targeting molecules in molecular imaging.
  • Radiopharmaceuticals: Intermediate in the production of compounds for diagnostic imaging procedures.
  • Research Chemical: Utilized in academic and industrial laboratories studying contrast media chemistry and pharmacokinetics.
  • Quality Control Reference Standard: Acts as a high-purity standard for analytical methods in pharmaceutical quality assurance.

Basic Information

Product Name γ-(3-(3-Amino-2,4,6-Trijod-Benzoylamino)-Phenyl)-Buttersaure [Germ An]
CAS No. 22708-53-8
Molecular Formula C17H15I3N2O3
Molecular Weight 651.93 g/mol
Synonyms γ-(3-(3-Amino-2,4,6-triiodobenzamido)phenyl)butyric Acid; 4-[3-[(3-Amino-2,4,6-triiodobenzoyl)amino]phenyl]butanoic Acid; Iopanoic Acid Intermediate; Germ An; 3-Amino-2,4,6-triiodo-N-[3-(4-carboxybutyl)phenyl]benzamide; Iodinated Benzamide Derivative; Contrast Media Intermediate; CAS 22708-53-8
EINECS Contact for details

Quality Control

Our production of this high-value pharmaceutical intermediate adheres to strict cGMP (current Good Manufacturing Practice) guidelines to ensure batch-to-batch consistency and traceability. Quality is verified through a comprehensive suite of analytical techniques including HPLC, NMR, and mass spectrometry. A detailed Certificate of Analysis (COA) is provided with each shipment, confirming identity, purity, and impurity profiles against stringent internal specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider using desiccants.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to structure
Identification (HPLC) Conforms to reference standard
Assay (HPLC) ≥ 98.0%
Related Substances (HPLC) Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Residual Solvents (GC) Complies with ICH Q3C
Heavy Metals < 20 ppm
Loss on Drying ≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.